Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Older Adults
100%
Late-life Depression
53%
Major Depressive Disorder
32%
Later Life
27%
Antidepressants
23%
Depressive Symptoms
22%
Randomized Controlled Trial
20%
Generalized Anxiety Disorder
19%
Hip Fracture
18%
Treatment-resistant Depression
17%
Remission
16%
Anxiety Disorders
16%
Placebo
16%
Venlafaxine
16%
Pharmacotherapy
16%
Clinical Trials
15%
Selective Serotonin Reuptake Inhibitors
13%
Randomized Clinical Trial
12%
Aripiprazole
12%
Antidepressant Treatment
10%
Anxiety Symptoms
9%
Elderly People
9%
Cognitive Impairment
9%
Treatment Outcome
9%
Ecological Momentary Assessment
9%
Escitalopram
9%
Executive Function
9%
Late-life Anxiety
8%
Mindfulness-based Stress Reduction
8%
COVID-19
8%
Treatment-resistant
8%
Bupropion
8%
Confidence Interval
8%
Functional Recovery
7%
Mental Health Care
7%
Older Patients
7%
Fluvoxamine
7%
Tolerability
7%
Depression Treatment
7%
Functional Outcome
6%
Mental Health
6%
Disability
6%
Comorbid Anxiety
6%
Depression Severity
6%
Treatment Response
6%
Mindfulness Training
6%
D-cycloserine
5%
Postoperative Delirium
5%
Ketamine
5%
Cognitive Function
5%
Medicine and Dentistry
Late Life Depression
24%
Antidepressant
15%
Randomized Controlled Trial
15%
Clinical Trial
12%
Treatment Resistant Depression
11%
Major Depressive Episode
11%
Mental Health
10%
Aripiprazole
10%
Randomized Clinical Trials
10%
Drug Therapy
10%
Placebo
10%
COVID-19
7%
Hip Fracture
7%
Venlafaxine
6%
Postoperative Delirium
6%
Bupropion
6%
Cognitive Defect
6%
Executive Function
6%
Geriatrics
5%
Quality of Life
5%
Anxiety Disorder
5%
Ketamine
5%